PHARMOS CORP
CIK 0000713275
Revenue (TTM)
—
Q3 Nov 2012
Net Income (TTM)
−$1.74M
−28.0% YoY
Q3 Nov 2012
EPS Diluted (TTM)
—
Q3 Nov 2012
Gross Margin
—
Q3 Nov 2012
Operating Margin
—
Q3 Nov 2012
Net Margin
—
Q3 Nov 2012
Free Cash Flow (TTM)
—
Q3 Nov 2012
Cash
$279.37K
Q3 Nov 2012
Total Debt
—
Q3 Nov 2012
Shares Outstanding
60.17M sh
Q3 Nov 2012
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.